TABLE 1.
Summary of response to study consent and adherence
| Center 1 (n = 30) | Center 2 (n = 30) | Overall (n = 60) | |
|---|---|---|---|
| Response to study consent | |||
| Proportion of consents (%) | 93.3 ± 17.3 (129/139) | 98.3 ± 6.3% (118/120) | 95.7 ± 13.2 (247/259) |
| Study completion rate (%) | 100.0 (30/30) | 100.0 (30/30) | 100.0 (60/60) |
| Response time, h | 0.3 [0.0–91.6] | 0.2 [0.0–43.3] | 0.2 [0.0–91.6] |
| Drug adherence | |||
| Administration of right drug (%) | 89.6 ± 20.6 (753/840) | 92.0 ± 17.9 (773/840) | 90.8 ± 19.2% (1526/1680) |
| Adherence to the drug administration schedule (%) | 75.7 ± 27.8 (636/840) | 62.5 ± 24.9 (525/840) | 69.1 ± 27.0 (1161/1680) |
| Procedural adherence | |||
| Whether the body temperature was measured (%) | 96.7 ± 4.2 (812/840) | 98.5 ± 5.4 (827/840) | 97.6 ± 4.9 (1639/1680) |
| Adherence to the procedural schedule (%) | 50.5 ± 24.7 (424/840) | 67.5 ± 22.6 (567/840) | 59.0 ± 25.0 (991/1680) |
Data are presented as mean ± standard deviation of the proportions in each subject (only overall values for study completion rate) and overall counts to total except for response time. Response time is presented as median [minimum‐maximum].